Log in or Sign up for Free to view tailored content for your specialty!
Menopause News
VIDEO: Mount Sinai conference spotlights latest treatments, wellness for midlife women
In this Healio video exclusive, Joanne Stone, MD, MS, and Susan S. Khalil, MD, discussed highlights from the second annual Mount Sinai Women’s Health Forum, a 1-day conference dedicated to the latest updates in care for midlife women.
Older age at natural menopause may increase asthma risk
Later age at natural menopause may be a risk factor for asthma, potentially due to prolonged estrogen exposure, data from a longitudinal study show.
Frequent, persistent hot flashes associated with 50% increased risk for diabetes
Women with frequent and persistent hot flashes and night sweats during the menopause transition are at increased risk for developing diabetes compared with women who do not experience vasomotor symptoms, researchers reported.
Log in or Sign up for Free to view tailored content for your specialty!
Women with PCOS at risk for emotional, uncontrolled eating in midlife
Women with vs. without polycystic ovary syndrome have a higher risk for emotional and uncontrolled eating behaviors at midlife, with contrasts observed among different phenotypes, according to findings published in Fertility and Sterility.
Making menopause mainstream: A conversation with Monica Christmas, MD, FACOG, MSCP
Interest in menopause and all things related to midlife women’s health continues to grow, and The Menopause Society is expanding to meet the demand.
FDA accepts new drug application for nonhormonal hot flash drug elinzanetant
The FDA accepted a new drug application for elinzanetant, a nonhormonal treatment for moderate to severe vasomotor symptoms associated with menopause, according to an industry press release.
Poor hot flash documentation in primary care setting leaves many midlife women untreated
Many postmenopausal women self-reported moderate or higher vasomotor symptoms in the primary care setting but remained untreated due to lack of electronic health record documentation, researchers reported.
Primary ovarian insufficiency more than doubles midlife multimorbidity risk
Women with premature ovarian insufficiency and early menopause have increased multimorbidity compared with women with menopause onset at an average age of 46 to 55 years, according to findings published in Fertility and Sterility.
Hypothyroidism does not worsen rate of cognitive decline for perimenopausal women
Women with hypothyroidism receiving levothyroxine treatment experienced similar cognitive decline during menopause as those without thyroid disease, according to data published in Thyroid.
Balance between excitement, inhibition key to treat hypoactive sexual desire disorder
CHICAGO — Many midlife women experience hypoactive sexual desire disorder, impacting both partner relationships and mental health, but FDA-approved treatments are available, according to a speaker.
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read